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A B S T R A C T
The aim of the present work is the characterization of smart auto-degradable microspheres composed of
calcium alginate/high methoxylated pectin containing an alginate lyase (AL) from Sphingobacterium
multivorum and levofloxacin. Microspheres were prepared by ionotropic gelation containing AL in its
inactive form at pH 4.0. Incubation of microspheres in Tris–HCl and PBS buffers at pH 7.40 allowed to
establish the effect of ion-chelating phosphate on matrix erodability and suggested an intrinsically
activation of AL by turning the pH close to neutrality. Scanning electron and optical microscopies revealed
the presence of holes and surface changes in AL containing microspheres. Furthermore, texturometric
parameters, DSC profiles and swelling properties were showing strong changes in microspheres
properties. Encapsulation of levofloxacin into microspheres containing AL showed 70% efficiency and 35%
enhancement of antimicrobial activity against Pseudomonas aeruginosa biofilm. Levofloxacin release from
microspheres was not changed at acidic pH, but was modified at neutral pH in presence of AL.
Advantageously, only gel matrix debris were detectable after overnight incubation, indicating an
autodegradative gel process activated by the pH. Absence of matrix cytotoxicity and a reduction of the
levofloxacin toxicity after encapsulation were observed in mammalian CHO-K1 cell cultures. These
properties make the system a potent and versatile tool for antibiotic oral delivery targeted to intestine,
enhancing the drug bioavailability to eradicate bacterial biofilm and avoiding possible intestinal
obstructions.
ã 2015 Elsevier B.V. All rights reserved.
Contents lists available at ScienceDirect
International Journal of Pharmaceutics
journal homepage: www.elsev ier .com/locate / i jpharm1. Introduction
Since the last decades, biopolymers are playing a major role for
the development of novel technologies in many fields and
particularly in the pharmaceutical and medical fields (Skaugrud
et al., 1999; Kalia and Avérous, 2011). There is a real need in
development of novel medical devices with increasingly functional
properties such as durability, flexibility, and strength, in addition to
improved biocompatibility, non-toxic and low costs. Consequently,
the development of novel smart devices based in natural polymers,* Corresponding author. Fax: +54 221 483 37 94x132/103.
E-mail address: grcastro@gmail.com (G.R. Castro).
http://dx.doi.org/10.1016/j.ijpharm.2015.10.050
0378-5173/ã 2015 Elsevier B.V. All rights reserved.coacervates, and hybrid materials are currently been explored in
our laboratory (Islan et al., 2012, 2013, 2014).
Among biopolymers, alginates have been long considered as
matrices for drug or cells encapsulation (Goh et al., 2012) and for
other applications in controlled transdermal or transmucosal drug
delivery of active substances (Sachan et al., 2009). Alginates are
linear anionic polysaccharides linked by 1–4 bounds containing
varying proportions of ß-manuronic acid (M units) and a-gulur-
onic acid (G units). Their properties of not being toxic, not
immunogenic, biodegradability and biocompatibility, added to a
“green” gelation in presence of divalent ions by “egg box junctions”
make them very suitable hydrogels for medical applications (Lee
and Mooney, 2012).
Another interesting group of biopolymers to be considered for
drug delivery applications is pectins. They are water-soluble
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residues of poly-a-(1,4)-D-galacturonic acids with different
esterification degrees (ED). Pectins can be classified as low
methoxylated (LMP: ED below of 40%), medium methoxylated
(MMP: ED 40–60%), and high methoxylated pectins (HMP: ED
higher than 60%). It has been reported that pectins played a key
role in interaction with antibiotics of the fluoroquinolones family,
improving the encapsulation of the drug and providing a
controlled release profile (Islan et al., 2012).
Fluoroquinolones like ciprofloxacin and levofloxacin are very
common antibiotics working as inhibitors of DNA gyrase and
topoisomerase IV causing bacterial death. Despite their effective-
ness, these antibiotics are commonly associated to undesirable
side effects (Paton and Reeves,1991; Carbon, 2001), mainly due to a
tendency to aromatic stack among themselves under physiological
conditions that reduce their bioavailability and become toxic
(Turcu and Bogdan, 2012). In this sense, encapsulation in smart
nano- and micro-biopolymeric devices are a novel technologies
potentially useful to provide effective controlled release of the
drugs and therefore reducing their toxic concentrations.
The combination of fluoroquinolones with therapeutic lytic
enzymes showed synergic effects on antibiotic diffusion and
represents an alternative to improve microbial infection therapies
as recently reported (Zhu and Yin, 2015). Particularly, alginate lyase
(AL) could play an active role in detaching pathogens immersed
into biofilms composed of bacterial alginate (Boyd and Chakra-
barty, 1994). AL acts over b-1,4-glycosidic linkages of alginate via
b-elimination reaction to produce oligosaccharides. The AL
biocatalytic activity could enhance the treatment of infections
caused by the biofilm-making Pseudomonas aeruginosa, an
opportunistic human pathogen usually found in several illnesses
and very difficult to eradicate once established. The most common
case is cystic fibrosis in which the bacteria are colonizing the lungs
and intestine walls producing strong biofilm architecture (May
et al., 1991; Cutting, 2015). Behind these circumstances, effective
devices for drug delivery are required showing enhanced
antimicrobial activity and particularly with the ability of displaying
autodegradative properties in order to avoid possible additional
intestinal obstructions by the matrix.
A few degradable matrices for molecular controlled release
have been reported previously addressing cell migration (Zhao
et al., 2005) or in cancer treatment (Ishida et al., 2008), but smart
autodegradative microspheres able to be activated under certain
environmental conditions and therefore modulate the release
profile of the bio-active molecules are still in their infancy.
In a previous work from our laboratory, microspheres
composed of alginate and HMP gels were able to co-encapsulate
ciprofloxacin and alginate lyase for potential oral treatment of
cystic fibrosis (Islan et al., 2013). However, the encapsulation
mechanism and the enzymatic behavior under physiological
environments were unclear and required further characterizations
for the medical application. To our best knowledge only few
reports proposed the enzymatic modification of gels and there are
no reports of an alginate lyase acting on alginate/HMP matrices
(Klak et al., 2013; Liu et al., 2013).
The aim of the present work is to study the auto-degradable
properties of a biopolymeric hydrogel made of alginate and high
methoxylated pectin containing alginate lyase and levofloxacin.
The effect of environmental factors such as pH and phosphate ions
on microsphere swelling and enzyme activity were analyzed.
Biophysical tests like morphological microsphere kinetic changes
and topology was followed by scanning electronic and optical
microscopies; texturometric and calorimetric analyses were also
performed. The antimicrobial activity of levofloxacin against P.
aeruginosa biofilm was finally tested in-vitro and the cytotoxicity of
microspheres and their components was evaluated in mammalianscells in order to investigate their suitability for use in living
organisms.
2. Materials and methods
2.1. Materials
Low-viscosity sodium alginate (Alg, MWav= 120 kDa) was
provided by Monsanto (Buenos Aires, Argentina). Levofloxacin
(Levo, (S)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methylpiperazin-
1-yl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic
acid), high methoxyl apple pectin (HMP, MWav = 160 kDa; DE: 70–
75%), TRIS (tris(hidroximetil) amino metano) and alginate lyase
(AL) from Sphingobacterium multivorum were purchased from
Sigma–Aldrich (Buenos Aires, Argentina). Ham’s F10 cell culture
media was from Microvet, Argentina; fetal bovine serum (FBS) was
from Internegocios SA Argentina. P. aeruginosa ATCC 15442 was
used in all experiments. Other reagents were of analytical grade
from commercially available sources and used as received from
Merck (Darmstadt, Germany) or similar brand.
2.2. Formulation and preparation of alginate based microspheres
containing levofloxacin and alginate lyase
Low-viscosity sodium alginate (2.0 wt%) was dissolved in
25 mM acetate buffer (pH 4.0) at room temperature, followed by
the addition of 100.0 mg/ml levofloxacin and 40.0 U/ml of AL under
gently stirring at 0 C. Alternatively, alginate (2.0 wt%) was mixed
with HMP (1.0 wt%) following the same procedure. Microspheres
were prepared by adding 2,0 ml of biopolymeric solution by drop
wise via a 20-gauge hypodermic needle connected to a peristaltic
pump with a flow rate of 0.2 ml/min (Watson Marlow 101U/R,
Cornwall, UK) into 10,0 ml of 500 mM CaCl2 in 1:1 water/1,2-
propyleneglycol mixture and stirred at 100 rpm for 20 min (Das
and Senapati, 2008; Islan et al., 2013). After that maturation time,
microspheres were filtered, washed with distilled water, frozen
with liquid nitrogen and lyophilized for further assays.
The experimental conditions selected for microspheres prepa-
ration were based on ionotropic gelation method in presence of
calcium ion dissolved in 1,2-propylene glycol–water (1:1) solution
to enhance the antibiotic encapsulation as previously reported
(Islan et al., 2013). The pH of the formulation was set at 4.0 because
of AL showed reversible inactivation under this experimental
condition and consequently the enzyme was not able to hydrolyze
the alginate before crosslinking. Also, it was established that the AL
is highly stable at pH 4.0 and 0 C during particle synthesis (Fig. S1a
and b). Another advantage of working at low temperature is related
to increase the matrix gelation process and reduce molecular
diffusion during encapsulation (Islan et al., 2012).
2.3. Evaluation of AL activity and stability studies
Alginate lyase (AL) activity was measured by mixing 75 ml of
enzyme solution (40.0 U/ml) with 1.925 ml of 1.0 wt% alginate (in
phosphate buffer 25 mM pH 7.4) and incubated at 37 C for 30 min.
The reaction was stopped by the addition of 2.0 ml of 100 mM
NaOH and the resulting absorbance was measured at 233 nm. One
AL unit was defined as the amount of enzyme capable of increase
1 unit of absorbance at 233 nm per min  ml of sodium alginate at
pH 7.4 and 37 C.
The AL activity into the microspheres was calculated consider-
ing the initial amount of enzymatic units added to the formulation
and the activity determined after immobilization and subsequent
dissolution of the matrix in 100 mM phosphate buffer (pH 7.40).
The stability of AL was studied as function of pH and
temperature in order to optimize the parameters for microspheres
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incubated with 1.0 ml of 50 mM KCl/HCl buffer (pH 1.2 and 2.0),
25 mM citrate buffer (pH 3.0), acetate buffer (pH 4.0 and 5.0) and
25 mM phosphate buffer (pH 6.3, 6.8, 7.4 and 8.2) at 37 C for
30 min. For thermal stability, AL (4.0 U/ml) was incubated at pH 7.4
(25 mM phosphate buffer) and at different temperatures (5, 20, 32,
37 and 42 C) for 30 min. In both cases, after incubation, the AL
activity was assayed at optimum conditions as previously
described. The 100% of activity was set by AL at 37 C and pH 7.4.
2.4. Measurement of total protein content
Protein content was measured using fluorescamine as follow:
50 ml of sample was mixed with 350 ml of 12.5 mM borate buffer
(pH 9.0) and 125 ml of fluorescamine (300 mg/ml). After 2 min,
fluorescence was measured at lex = 390 nm and lem= 478 nm
(PerkinElmer, LS 50B spectrofluorimeter) using proper calibration
curve.
2.5. Determination of levofloxacin and AL encapsulated into alginate
based microspheres
Microspheres were separated by filtration and the Levo
concentration was spectrophotometrically determined in the
filtrate solution at 295 nm, using an appropriate calibration curve
(UV–vis Beckman DU640 spectrophotometer). The encapsulation
percentage was calculated as follows:
Encapsul ð%Þ ¼ ½ðQ0  ðCr  VÞÞ  100
Q0
ð1Þ
where Q0 = initial Levo amount (mg), Cr = Levo concentration in the
filtrated solution (mg/ml), and V = volume of filtrated solution (ml).
The same Eq. (1) was used to estimate the AL activity and total
protein content of filtrated solutions, but redefining the param-
eters as follow: Q0= initial AL units (U)/initial total protein amount
(mg) and Cr = activity of AL (U/ml)/concentration of total protein
(mg/ml) in the filtrated solution.
Alternatively, the encapsulation percentage was determined by
quantifying the antibiotic release after total matrix degradation.
The microspheres (100.0 mg) were weighed and incubated to
complete disintegration in 1.5 ml of 100 mM phosphate buffer (pH
7.4) following by centrifugation (10,000  g for 10 min). The
antibiotic and protein concentrations were determined in the
supernatant by absorbance or fluorescence respectively as
mentioned before.
2.6. Scanning electron microscopy (SEM) images
Freeze-dried microspheres were prepared for SEM observation
by sputtering the surface with gold using Balzers SCD 030
metalizer and obtaining layer thickness between 15 and 20 nm.
Surface and morphology of microspheres were observed using
Philips SEM 505 model (Rochester, USA), and processed by an
image digitalizer program (Soft Imaging System ADDA II (SIS)).
2.7. Roughness analysis
SEM images were analyzed by ImageJ software (NIH, USA). The
roughness of the surface was reflected by the standard variation of
the gray values of all the pixels on the image. First, the SEM image
files were converted to 8-bit images. Then, all the pixels were
selected and statistically measured with the software. The less the
standard variation value is, the smoother the surface is. Histograms
were performed by duplicate of SEM images at 710 magnifica-
tion.2.8. Differential scanning calorimetry (DSC) analysis
The DSC profile of the samples was obtained using a TA-
Instrument DSC Q2000. Briefly, 5.0 mg of lyophilized microspheres
were placed in a standard aluminum pan, hermetically closed and
heated at a constant rate of 10 C/min from room temperature to
225 C, under 20 ml/min nitrogen purging. All samples were run in
triplicate.
2.9. Swelling kinetics
Vials containing weighed freeze-dried microspheres (100 mg)
were incubated in 1.0 ml of TRIS buffer saline (TBS: 150 mM NaCl,
10 mM TRIS; pH 7.4) or 1.0 ml of phosphate buffer saline (PBS:
137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 2 mM KH2PO4; pH 7.4)
at 37 C. Every 1 h, one vial was taken and the liquid media was
removed, while microspheres were immersed into distilled water
for 10 s to wash out the buffers. Later, they were placed on
absorbent paper to remove the excess of liquid from the surface,
weighed and kept in capped tubes for further texturometric assays.
Swelling was expressed as percentage of microspheres weight
increment. The swelling degree with a value of 0% indicates that
microspheres are totally disintegrated.
The removed liquid media was spectrophotometrically ana-
lyzed to determine AL activity at each measurement point.
2.10. Optical microscopy
The microsphere swelling and erosion determined in presence
of TBS and PBS buffers were observed at different intervals of time
in an optical microscope (Leica DM 2500, Germany).
2.11. Measurement of texturometric parameters
Microsphere textures was analyzed in a TAXT 2i Texture
Analyzer (Stable Micro Systems Ltd., UK) equipped with a loading
cell of 25 kg and a cylindrical metal compression plate of 75 mm
diameter (p75). The texture profile analysis (TPA) consisted in two
compression cycles at 0.6 mm/seg to 30% of the original micro-
spheres height (Dini et al., 2014). In each assay, three microspheres
were simultaneously compressed. Data was processed with the
Texture Expert1 software and the textural parameters (hardness/
firmness) were calculated from the TPA curve of force (N) vs time
(seconds). Hardness (N) is defined as the peak force during the first
compression cycle and is expressed in Newton units. The results
represent the average means of at least triplicate tests.
2.12. Release studies of levofloxacin from alginate based microspheres
Freeze-dried microspheres (100 mg) were placed in a 3-ml glass
vial containing 1.5 ml of 50 mM KCl/HCl buffer (pH 1.20, simulated
gastric conditions) or 40 mM phosphate buffer (pH 7.40, simulated
intestinal environment) and incubated in a thermostatted orbital
shaker at 100 rpm and 37 C. Samples (0.5 ml) were taken out at
different times and absorbance was measured at the Levo
maximum wavelength corresponding to each buffer (293 and
286 nm at pH 1.20 and 7.40, respectively). Finally, 0.5 ml of fresh
media was added back to refill the reaction volume and the vials
were placed back.
2.13. Antimicrobial assay of levofloxacin (Levo) containing
microspheres against artificial biofilm of P. aeruginosa
Levo activity was tested against P.aeruginosa ATCC 15442 using
modified disk diffusion method, replacing disks for microspheres.
Briefly, five colonies of the microorganism were taken and
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adjust the turbidity of the culture to less than 3.0  108 CFU/ml
(0.5 McFarland scale). Agar plates were loaded with 25 ml of
Mueller–Hinton medium in 100 mm diameter Petri dishes and
inoculated within 15 min after adjusting the turbidity of the
inoculum suspension, using sterile cotton swab dipped into it.
After that, a thin layer of sodium alginate (1.0 wt%) was added to
cover the whole plate surface (the pH of the mixture was kept
around 7.0 by the agar medium and considering that P. aeruginosa
is non-fermentative bacteria growing mainly using oxidative
metabolism). Twenty minutes later, the microspheres were placed
on the surface and incubated at 37 C for 24 h. Then inhibition
zones were determined.
2.14. Cytotoxicity of the matrix tested in chinese hamster ovary (CHO)
cells
An initial screening of the potential cytotoxicity of the matrix
and its components was preliminary assessed by the colorimetric
MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bro-
mide) assay, which is based on the ability of living, metabolically
active cells to cleave a tetrazolium salt (Weyermann et al., 2005).
The assay was developed in the chinese hamster ovary cell line
subclone K1 (CHO-K1), obtained from the IMBICE cell repository,
which was selected as in vitro model due to its wide use for in vitro
toxicity studies and the uniform properties it exhibits.
2.14.1. Sample conditioning
A screening of cell viability in CHO-K1 cells with a wide range of
Levo concentrations showed that above 200 mg/ml cellular
viability significantly decreased. Based on that, the cytotoxicity
of the matrix containing Levo and the free antibiotic was tested at
0, 50 and 200 mg/ml. The microspheres (250 mg) were completelyFig. 1. SEM images of microspheres: alg/AL at 100 (a) and 710 (b); alg-HMP/AL at 10
surface images analyzed by ImageJ software.disaggregated in 2.0 ml of 100 mM phosphate buffer (pH 7.40) at
37 C for 30 min under constant shaking. The resulting suspension
was centrifuged 5 min at 9000  g and the cytotoxicity was tested
in the supernatant. For free Levo, a stock solution of 10 mg/ml was
prepared in 100 mM acetate buffer (pH 4.0) and diluted with sterile
distilled water to reach an intermediate concentration which was
finally adjusted with cell culture media.
2.14.2. Cell viability
CHO cells were grown in Ham’s F10 medium supplemented
with 10% FBS, penicillin (100 U/ml) and streptomycin (100 mg/ml)
at 37 C and 5% CO2 atmosphere. They were seeded on 96-well
plates at a density of 1 104 cells/well and were allowed to adhere
for 24 h. Then, cells were exposed to: free Levo (0, 50 and 200 mg/
ml);the empty matrix; the matrix containing the Levo (considering
a 70% of antibiotic encapsulation, with a value of 11 mg/mg matrix),
matrix containing the AL (encapsulation percentage of 90%) and
the matrix with both active components (Levo–AL) for 24 h. Once
incubation time was completed, medium was carefully discarded
and a volume of 100 ml of MTT solution (0.5 mg/ml in medium
without FBS and phenol red) was added to each well. After 3 h of
incubation, the presence of violet crystals inside the cells was
monitored by optical microscopy. Wells content was discarded,
carefully washed with PBS and 100 ml of DMSO was added to
extract formazan crystals. After a short incubation time at room
temperature, the absorbance at 550 nm was measured. The assay
was performed in 3 independent experiments by sextuplicate.
2.15. Statistical analysis
Each experiment was carried out at least in triplicates.
Comparisons of the means were performed by analysis of variance0 (c) and 710 (d) magnifications. The insets show the grey scale histograms of
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Fisher’s least significant difference test at a P < 0.05.
3. Results and discussion
3.1. Preparation of microspheres
Two autodegradative gel microsphere formulations based on
alginate containing or not HMP were developed. In both
formulations the AL entrapment was higher than 90% (determined
by total proteins measurement) but showing significant differ-
ences in AL activities. The Alg/AL microspheres displayed 90% AL
activity after immobilization, meanwhile a 76% enzyme activity
was detected in the Alg-HMP/AL formulation. That decrease in the
AL enzyme activity could be attributed to the presence of HMP,
which possibly reduce the AL contact with the alginate chains and
could also interact with the enzyme (Islan et al., 2014).
All the tested formulations produced particles in a narrow size
distribution with about 1 mm diameter under native conditions,
but the particles shrink to 800  50 mm diameter after freeze-
drying process.
3.2. Characterization of microspheres
The microsphere morphology and surface pattern character-
istics were analyzed by SEM (Fig. 1). Alg/AL microspheres showed
almost spherical shape with some irregularities and holes on
surface (Fig. 1a). However, an approach at 710x magnifications
revealed a good compatibility of the matrix combining the alginate
in presence of the AL in its inactive conformation. A smooth profile
was observed through analysis by ImageJ software (Fig. 1b). On the
other side, the matrix composed of alg-HMP/AL was characterized
by spherical microspheres with a rougher surface based on theFig. 2. DSC thermograms of microspheres: (1) algstandard deviation which was increased from 17 to 32 for alg/AL
and alg-HMP/AL formulations respectively. Also, the alg-HMP/AL
microspheres were displaying distinctive structural aggregates like
knots covering their surface (Fig. 1c and d). The folds on
microsphere surface were possibly composed of pectin, and
probably partially extruded form the inner alginate gel structure
because of lower interchain crosslinking degree in presence of
calcium ion due to its high methoxylation degree (Braccini and
Pérez, 2001).
Thermal analysis of the microspheres was performed by DSC
(Fig. 2). Alginate microspheres showed an endothermic peak at
245 C meanwhile the alg/AL microspheres exhibited a peak at
239 C. The 6 C shift to lower temperature values are indicative of
more labile structure and/or porous architecture, reason why
water molecules are more exposed and prone to migrate out of the
matrix. The results were in concordance with SEM observations,
which suggests more irregularities on surface compared with
alginate formulations without the enzyme (Islan et al., 2013). In the
case of alg-HMP microspheres the DSC profile differs only in 2 C
when the AL was incorporated, suggesting a minor effect of the
enzyme on the matrix structure.
When microspheres were incubated in a liquid medium and the
pH inside the matrix was slowly shifted from acid to neutral values,
the AL become active and started to degrade the alginate gel
microsphere. The influence of the buffer was studied, considering a
calcium-chelating buffer (PBS) and a non-chelating buffer (TBS),
keeping the pH at 7.40. It is well known that chelating agents like
phosphate are forming complex with the calcium present into the
microspheres and breaking the bridges between the alginate
chains, and consequently the gel matrix stability is compromised
(Almeida and Almeida, 2004). Under these conditions, the swelling
properties of microspheres were analyzed (Fig. 3). Alginate gel
microspheres incubated in TBS buffer was able to incorporate, (2) alg/AL, (3) alg-HMP and (4) alg-HMP/AL.
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Fig. 3. Swelling of microspheres in TBS (a and b) and PBS (c and d) buffers at pH 7.40 and 37 C. Symbols: *, alg; , alg/AL; !, alg-HMP and 4, alg-HMP/AL composites.
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considered as the water saturation time for this formulation.
Instead, the microspheres composed of alg/AL underwent a
process of initial swelling up to 3 h, point from which the
environmental conditions favored the AL activation (initially
inactive at pH 4.0) and started the evident autodegradation of
the matrix with a gradual loss of mass follow by complete gel
structure disintegration after 5 h of incubation (Fig. 3a).
On the other hand, the behavior of alg-HMP microspheres in
TBS medium was similar. The matrix without the enzyme showed a
progressive swelling similarly to alginate microspheres. However,
the response in presence of the AL differs in the water absorption.
The alg-HMP/AL microspheres also showed a maximum swelling
degree in 3 h, but reaching a value of 400% at higher rate. The
difference in water incorporation compared to alginate micro-
spheres is possibly due to the presence of HMP, a biopolymer able
to bind large quantities of water molecules by hydrogen bonds
(Thakur et al., 1997). After 3 h, the alg-HMP/AL matrix began to be
degraded by the enzyme and was completely eroded at 5 h
(Fig. 3b).
The gel microspheres incubated in calcium chelating buffer
(PBS) showed different swelling profiles based on the matrix
composition. In the absence of AL, the gel matrix composed of
calcium alginate began to swell until 4 h, showing a high swellingdegree of 2000%. This fact could be explained considering that free
alginate chains are available to bind water molecules after the
uptake of calcium ions present in the gel network by the
phosphates from PBS (Bajpai and Sharma, 2004). After 4 h,
occurred an erosion process due to the loss of calcium bridges
within the structure, concomitantly with the dissolution of the
matrix. Meanwhile, the autodegradation process of the micro-
spheres is more pronounced in the presence of encapsulated AL
from the first time of incubation which is resulting in low rate of
swelling and considerable loss of gel matrix mass (Fig. 3c). As
similar as previously observed, the alg-HMP microspheres showed
high initial swelling. In the case of alg-HMP/AL matrix, the swelling
degree was more pronounced compared to alg microspheres, but
the total autodegradation of the matrix was also produced after 4 h
(Fig. 3d). These results are indicating that AL is able to hydrolize
alginate chains from the inside of the matrix, even in presence of
other biopolymers, like pectin, structurally similar to alginate
which highlights the biocatalytic specificity of the enzyme.
The environmental effect of pH and buffer chelating activity
was used to study the microsphere gel stability by tracing the
products of Alginate Lyase (AL) activity released from the inside of
the matrix (Fig. S2). The microspheres were made by ionotropic
gelation using calcium, and two relevant effects over the gel
stability were superposed: the pH and calcium concentration
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used at the same pH to discriminate both effects: Tris–HCl (TBS,
non-chelating buffer) and phosphate (PBS, calcium-chelating
buffer). Statistical analysis of the AL products released from the
microspheres in TBS and PBS buffers are suggesting that the
autodegradation of the matrix in both experimental conditions are
coming from inside the particles (Fig. S2). However, in the case of
TBS, the release of AL increases linearly up to the 2 h and
afterwards began to rise slowly. This behavior is probably
produced because of AL is mainly acting on the crosslinked
alginate chains (e.g., the “egg box” structure) and the access of the
AL active site to the substrate could be restricted. On the other side,
the products of AL activity in time at PBS were increasing linearly
until reach the total disintegration of microspheres at 4 h. This fact
can be attributed to the action of phosphate ions that are
competing for the calcium within the matrix with two con-
sequences: (1) enhancing the matrix erosion; (2) releasing free
alginate chains that are more accessible for AL activity. Under these
considerations, it is possible to explain the faster disintegration of
microspheres in PBS buffer
In order to elucidate changes in hardness of microspheres after
incubation in the different buffers, the texturometric parameter
was determined at a critical time (in this case, 2 h) (Table 1). The
hardness parameter (or firmness) usually gives information about
the resistance of the gel matrix to compression (Lau et al., 2000).
The hardness of fresh alg/AL microspheres was 25% lower than
alginate microspheres, indicating a more labile or porous structure.
On the other side, alg-HMP/AL microspheres showed similar
hardness values in comparison with alg-HMP microspheres,
suggesting that AL is not interfering in the alg-HMP matrix
structure. After incubation of microspheres at different buffers, a
decrease in hardness with respect to controls (not incubated fresh
microspheres) was observed in all cases. A significant change
(P < 0.05) was elucidated for microspheres containing the enzyme,
demonstrating the auto-degradability of the matrix due to AL
activation at pH 7.40. The effect is more prominent after incubation
of non-containing AL microspheres in PBS buffer because of the
matrix erodability was simultaneously enhanced by phosphate
ions that are taking out calcium from the matrix. However, in the
case of AL containing microspheres, the reduction was indepen-
dent of the buffer type, indicating that matrix erodability was
regulated mostly by enzyme activity.
The swelling behavior of the biopolymeric microspheres
containing the AL was corroborated by optical observations in
time after incubation in TBS and PBS (Fig. S3). It was seen that alg/
AL microspheres were more prone to degradation in TBS than alg-
HMP/AL microspheres, with the appearance of holes on surface
after incubation for 2 h and loss of their almost entire structure
after 4 h incubation. In TBS, both matrices suffered a less
autodegradation process and after 4 h incubation the matrix
maintain some structure but with cracks on the surface and an
evident loss of sphericity.
SEM images confirmed the autodegradation of microspheres
(Fig. 4). The alg/AL and alg-HMP/AL microspheres showed holes onTable 1
Hardness of microspheres in Ca2+ chelating (PBS) and non-chelating (TBS) buffer at pH
Conditions Hardness of microspheres (New
Alg 
No incubated fresh microspheres 0.56  0.07a
After incubation
TBS (2 h) 0.43  0.01b
PBS (2 h) 0.37  0.02c
Different letters within the same column indicate significant differences (P < 0.05).their structure and changed their spherical form to a “ring” shape
(like donut), indicating that AL was activate and work even from
inside of the microspheres at neutral pH for 2 h incubation. Also,
both matrices were completely disintegrated with particulate
dispersion lower than 5 mm after 4 h incubation.
In summary, the biocatalytic mechanism of microspheres
autodegradation is established and schematized in Fig. 5 in order
to provide a clear understanding of the process.
3.3. Incorporation of levofloxacin into microspheres and release
studies
Based on a previous work from our lab (Islan et al., 2013),
encapsulation of levofloxacin was performed into microspheres of
alg and alg-HMP (with or without the AL) prepared in a calcium
solution containing 1,2-propylene glycol and high encapsulation
percentages were obtained. Meanwhile alg microspheres exhibited
a efficiency of 75.1 1.6%, the alg-HMP microspheres showed an
encapsulation percentage of 70.3  0.2%, which corresponds to
102 mg of Levo per gram of matrix. The encapsulation percentage in
presence of AL showed no significant differences (P  0.05) in both
cases (74.0  3.0% and 68.8  2.0%, respectively).
The Levo release from microspheres was evaluated at two pH
conditions: acidic (1.20) and slightly alkaline (7.40), which are the
physiological pH’s of stomach and intestine respectively (Fig. 6). It
was found that the alg-HMP/AL microspheres showed some
advantages for oral administration compared to free Levo
administration and the alg/AL microspheres (Fig. 6a). The alg-
HMP formulation was providing a more controlled release of
levofloxacin especially under gastric conditions. The Levo release
from alg and alg/AL microspheres showed a burst release at pH 1.2,
reaching the 100% in less than two hours and thus, the availability
of the drug that hypothetically would reach the intestine was
drastically reduced. This is mainly produced because the rapid
dissolution of the free Levo at acidic pH’s (data not shown). The
presence of pectin (HMP) in the formulation plays a key role by
interacting with the fluoroquinolone and increases sustainability
in the antibiotic release as previously reported by our laboratory
(Islan et al., 2012, 2013; Martinez et al., 2012). In agreement, the
release of Levo from alg-HMP and alg-HMP/AL was reduced (about
40% in two hours) both with similar values at acid pH, indicating
that the AL was inactive (Figure S1) and therefore, no degradation
of the matrix had occurred. Nevertheless, taking into account that
normal gastric residence times are usually in the range between 5
and 120 min depending on food contain (Mojaverian et al., 1987;
Shah et al., 2009), it is possible to consider the administration of
the antibiotic dose in the microspheres before ingestion of foods
which is reducing the particle residence time in the stomach and
allows to reach the intestine approximately in 15 min. In this sense,
the success of the alg-HMP and alg-HMP-AL formulations is the
low release of levofloxacin from the matrices, only 15% and the 10%
respectively, compared with 60% antibiotic release in the alg and
alg/AL formulations in 15 min. 7.40 after 2 h incubation at 37 C.
ton)
Alg/AL Alg-HMP Alg-HMP/AL
0.41  0.03a 0.62  0.02a 0.61  0.03a
0.31  0.04b 0.52  0.02b 0.40  0.03b
0.32  0.01b 0.41  0.08c 0.39  0.04b
Fig. 4. Autodegradation of matrices after incubation at neutral pH and different times: alg/AL microspheres at 2 h (a) and 4 h (b); alg-HMP/AL microspheres at 2 hs (c) and 4 hs
(d).
Fig. 5. Scheme of the autodegradation mechanism of microspheres (MSs): first, the AL is encapsulated at pH 4.0 at its inactive form and MPs are freeze dryer; then, at liquid
media MSs begin to swell and at pH 7.4 the AL is converted to its active form: in TBS the AL activity is slow because is working on alginate chains mostly crosslinked with
calcium; in PBS the AL activity against MSs is higher because phosphate ions are taking the calcium from the network, releasing more free alginate molecules that are more
accessible for AL activity.
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Fig. 6. Release profile of levofloxacin from microspheres at pH 1.20 (a) and pH 7.4 (b). Symbols: *, alg; , alg/AL; !, alg-HMP and4, alg-HMP/AL composites. Values shown
are the means + SD from triplicate samples (n = 2).
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prevent the fast enzyme inactivation by acid pH (Fig. S1a). The
hydrophobic motifs from the HMP structure would provide
protection for the enzyme (AL activity) reaching the intestine
almost “alive” (active) (Islan et al., 2013). According to this
observation, the alg-HMP/AL composite was able to retain the 26%of the initial AL activity at pH 1.2 and 37 C after 2 h incubation. On
the other side, free AL and the alg/AL microspheres completely lost
the enzymatic activity under the same experimental conditions.
On the other hand, almost 100% of the Levo was release from alg
and alg/AL formulations under intestinal conditions (pH 7.4) in two
hours, meanwhile the antibiotic release was reduced to 34% and
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at the same incubation time (Fig. 6b). Later, these microspheres
will be fully disintegrated at intestine producing the total release of
Levo in about 4 h (Fig. 3), in agreement with the human small
bowel transit average time of 4.0  1.4 h previously reported (Read
et al., 1986; Baluom et al., 1998).
It was possible to observe that in the case of alg-HMP/AL
microspheres the Levo kinetic release at initial time-points in pH
1.2 and 7.4 were 30% and 35% in 60 min, respectively, showing
minimal statistically differences, because of AL irreversible
inactivation at acid pH. Besides, the Levo release from the
microspheres were 42% at pH 1.2 and 51% at pH 7.4 after two
hours incubation and displaying a 9% difference, which confirmed
the AL activation at further times at neutral pH’s.
Finally, the ability of alg-HMP/AL microspheres to be auto-
degraded at intestinal conditions and release active enzyme is an
attractive feature to treat intestinal infections. Particularly in the
case of P. aeruginosainfections, because the AL will be breaking
down the bacterial exogenous alginate matrix that composed the
biofilms, making more accessible the antibiotic for acting over the
bacteria (Boyd and Chakrabarty, 1994).
Based on the present results, the alg-HMP/AL microspheres will
be considered for further studies along the work.
3.4. The antimicrobial activity of microspheres
To assess the antibacterial activity of the encapsulated Levo,
alg-HMP and alg-HMP/AL microspheres were put in contact with
agar plates containing P. aeruginosa growing on surface (Fig. 6).
Additionally, the agar plate was covered with a thin layer of
alginate 1.0 wt%, to simulate a diffusional barrier for the antibiotic.
The results were of great interest and remarked the relevance of
the AL into the formulation: they showed how alg-HMP micro-
spheres were capable to produce a bacterial inhibitory halo
(14.8  0.1 mm) but a considerable enhanced inhibition
(20.0  2.0 mm) was observed with alg-HMP/AL. This result
indicates that the enzyme is improving in a 35% the antimicrobial
activity of Levo, not only favoring the release from microspheres,
but also degrading the external bacterial alginate film and
enhancing its diffusion across that barrier.
3.5. Cytotoxicity studies of microspheres
In vitro cytotoxicity of the alg-HMP matrix and the effect of the
presence of free and encapsulated Levo were studied in cell
cultures. The presence of the AL, encapsulated alone in the matrix
as well as together with Levo, was also evaluated (Fig. 7). Free LevoFig. 7. Antimicrobial activity of microspheres against Pseudomonas aeruginosaimmersed concentrations in the range of therapeutic serum concentrations,
50 and 200 mg/ml, were selected for the tests (Swoboda et al.,
2003). Therefore, the amount of Levo containing matrix added to
the cell culture medium was adjusted to reach those Levo
concentrations and considering the antibiotic release after
processing. Also, gel matrixes containing AL without the antibiotic
were tested (corresponding to 4.5 and 18.2 mg of matrix/ml).
Control in presence of phosphate buffer was also carried out in
order to detect any other effect on cell culture viability. Viability
controls (untreated cells) and cells treated with the two concen-
trations of dissolved matrix were performed by the MTT assay
(Fig. 7a). No significant differences in cell viability were observed
between the control cells and the cells exposed to both matrixes.
Similar results were obtained when controls were compared with
phosphate and alg/HMP-AL, indicating no deleterious effects of the
different matrix components on cell viability. In this regards and
considering the potential cytotoxicity of free Levo, as well the
combinations of it with the matrixes and the enzyme, the
differences were clearly observed. Levo treatment decreased
CHO-K1 cell viability in a concentration-dependent manner
(P < 0.01) as displayed in Fig. 7b. In comparison to the control
group, the cell viability at 50 and 200 mg/ml decreased to 87% and
65%, respectively. Considering the molecular characteristics of
fluoroquinolones and the intrinsic toxicity of Levo, these results are
in agreement with previous literature (Bai et al., 2014; Liu, 2010)
and sustain the encapsulation as an alternative to reduce cell
toxicity an enhance antibiotic efficacy (Islan et al., 2012, 2013).
Interestingly, encapsulated Levo showed reduced effects on cell
viability, even at 200 mg/ml. In this sense, no significant differences
were observed compared to the control cells at 50 mg/ml (P > 0.05),
being slightly cytotoxic at 200 mg/ml, where a decrease of 19% was
detected. However, not a major difference was observed when
comparing free and encapsulated Levo at 50 mg/ml (P  0.05), but a
significant difference was found at the antibiotic concentration of
200 mg/ml (P < 0.05), suggesting a positive tendency to diminish
Levo toxicity by the encapsulation procedure. It could be estimated
that the presence of dissolved biopolymers would also decrease
the toxicity of the drug in mammalian cells. Finally, the co-
encapsulation of Levo and AL did not show any significant variation
when is compared with encapsulated Levo (Fig. 7b). These results
support the hypothesis that AL would not interfere with Levo
activity on cell viability, but it is improving the Levo release. In this
sense, under the tested conditions, we could conclude that the alg-
HMP matrix presents no toxicity in the tested mammalian cells,
and the encapsulation of Levo in the alg-HMP gel matrix would
reduce the toxic effects associated with the administration of the
free antibiotic. The co-encapsulation with the AL enzyme couldinto an artificial alginate biofilm: left, alg-HMP/AL and right, alg-HMP microspheres.
a
b
Fig. 8. Cytotoxicity assay by MTT method tested in CHO-K1 cells of: (a) phosphate ions, the matrix of alg-HMP and the AL containing matrix. Two concentrations were
evaluated: 4.5 mg/ml (black) and 18.2 mg/ml (grey); (b) free Levo, Levo encapsulated into the matrix and the Levo/AL containing matrix. Two Levo concentrations were tested:
50 mg/ml (black) and 200 mg/ml (grey). No treated cells (control) were indicated as a striped column.
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undesirable side effects (Fig. 8).
4. Conclusions
In the present study, the ability of alginate lyase to be
immobilized and encapsulated in its inactive form into an alginate
based matrix was demonstrated. Furthermore, the matrix shows
auto-degradable properties when microspheres reach optimum
environmental conditions for AL activity. The incorporation of high
methoxylated pectin into the formulation gives interesting
properties in swelling capability and morphology of microspheres,
but does not affect the AL activity. However, the pectin can beutilized to improve and/or modulate the encapsulation and
controlled release of a fluoroquinolone antibiotic (levofloxacin).
Moreover, the presence of AL can control and increase the
antibiotic release from the matrix, due to the extensive depo-
lymerization of alginate chains. This fact is reflected in a mass loss
and the appearance of holes on microspheres surface observed by
OM and SEM.
The antimicrobial activity of microspheres against P. aeruginosa
is enhanced when the alg matrix contains AL, because of AL is
increasing the antibiotic diffusion through the biofilm. Surprising-
ly, no residues of gel matrix are detectable at naked eye after
overnight incubation, indicating that the microspheres are totally
autodegradable and allow to release the loaded drug.
964 G.A. Islan et al. / International Journal of Pharmaceutics 496 (2015) 953–964Widening the application of the system in pharmaceutical and
biomedical areas, the microspheres did not show considerable
cytotoxic effects on mammalians cells and the presence of
biopolymers could play a key role in reducing the toxicity of the
Levo.
The advantage toward the existing materials in the market is
that the present development of the alginate gel matrix can
modulate the release of biological active molecules through the
autodegradative microspheres under physiological conditions and
without any toxic residue. Particularly, the matrix can be an
excellent candidate for cystic fibrosis disease therapy, not only for
actively release an antibiotic at intestinal conditions, but also for
the capability to be completely degraded and avoid a possible
intestinal obstruction. Furthermore, the presence of AL will help
the antibiotic diffusion across the biofilm barrier made by
Pseudomonasspp. Also, based on the characteristic of the hydrogel
that can be extensively tailored by the HMP and the AL content, the
morphology is not only restricted for production of micro- and
nano-particles, but also novel films or 3D structures with smart
autodegradative properties could be developed.
Considering these facts, the matrix shows very interesting
properties that can be tailored according to the needs of specific
biomedical application and/or personalized medicine.
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